PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E952. A total of 2 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -98.6% | 300 | -97.6% | 0.00% | – |
| Q2 2023 | $345 | -35.9% | 12,500 | -46.6% | 0.00% | – |
| Q1 2023 | $538 | +1279.5% | 23,400 | +550.0% | 0.00% | – |
| Q4 2022 | $39 | -98.0% | 3,600 | +1100.0% | 0.00% | – |
| Q3 2022 | $2,000 | -99.7% | 300 | -99.6% | 0.00% | -100.0% |
| Q2 2022 | $592,000 | -67.3% | 74,900 | -2.0% | 0.00% | -50.0% |
| Q1 2022 | $1,809,000 | +30050.0% | 76,400 | +38100.0% | 0.00% | – |
| Q4 2021 | $6,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | +12.5% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | +300.0% | 200 | +19900.0% | 0.00% | – |
| Q1 2021 | $2,000 | -75.0% | 1 | -75.0% | 0.00% | – |
| Q4 2020 | $8,000 | +14.3% | 4 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,000 | $200,160 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 300 | $5 | 0.00% |